peroxidase
(TPO) autoantibodies was studied to know whether anti-TPO autoantibodies are closely implicated in the pathogenesis of human autoimmune thyroid diseases.
As a result of analyzing 14 patients' sera, 7 with Graves' disease and 7 with Hashimoto's thyroiditis, anti-TPO autoantibodies were found to consist of mainly IgGi subclass.
Percentages of both IgGi and IgG2 subclasses in IgG class of autoantibodies corresponded to those in the normal serum composition, whereas IgG3 subclass was scarcely contained in anti-TPO autoantibodies and IgG4 subclass markedly increased. It was thought that anti-TPO autoantibodies had a capability to lyse thyroid follicular cells by the mechanism of antibody-dependent complement-mediated cytolysis, because IgG1 and IgG2 subclasses of antibodies can fix complement and TPO locates in apical membrane surface of thyroid follicular cells. Comparing Graves' disease with Hashimoto's thyroiditis, mean percentages of both IgGi and IgG2 subclasses of 2 groups were statistically different. Namely, sera of patients with Graves' disease had higher and lower mean percentages of IgG1 and IgG2 subclasses of autoantibodies, respectively, than those with Hashimoto's thyroiditis, though no plausible explanation for these differences can be offered at the present time.
It was recently reported that anti-thyroid peroxidase (TPO) autoantibodies consist of mainly immunoglobulin G (IgG) in human autoimmune thyroid diseases (Portmann et al., 1985; Czarnocka et al., 1985; Kotani et al., 1986) and that TPO serologically constitutes a major thyroid-microsomal antigen (Kotani et al., 1986) . TPO locates not only in cytoplasmic organelles but also in apical membrane surface of thyroid follicular cells. Its epitope is also exposed to follicullar lumen (Umeki et al., 1985) .
The above findings suggest that TPO may play an important role in the pathogenesis of human autoimmune thyroid diseases, because TPO as a cell surface antigen can become a target in the immune reaction. Therefore, TPO should have been Preparation of human TPO Human TPO was purified on a moloclonal antibody (mAb)-assisted immunoaffinity column using recently established murine mAb to human TPO (mAb 38E). All procedures were carried out by the same method as described previously (Nakagawa et al., 1985 ; Kotani et al., 1986 , 1982) , because dm-TPO was nonspecifically bound to alkaline phosphatase-coupled goat or rabbit IgG. The digested sample was further purified on an immunoaffinity column and on a Sephacryl S-300 column (Pharmacia Fine Chemicals, Uppsala, Sweden). The final enzyme preparation (termed "dmtm-TPO") had a guaiacol oxidation activity of 336 units/mg protein and a ratio of absorbance of 413 nm to that at 280nm (RZ) of 0.65 as a purity index. TPO activity was determined as described previously (Ohtaki et al., 1982) .
Monoclonal antibodies mAbs to IgG subclasses and light chains were purchased from Miles-Yeda (Rehovot, Israel) and Bethesda Research Lab. (BRL) Inc., Gaithersburg, Md., as shown in Table 2 . They were used at 
Results

Measurement of anti-TPO autoantibodies IgG class and IgG subclasses of anti-TPO autoantibodies
were measured by microELISA using highly purified human TPO as a target. All sera contained IgG class of anti-TPO autoantibodies but per- to the distribution of IgG subclasses in normal serum, whereas Parkes et al. (1984) reported that the percentage of IgG4 subclass of autoantibodies markedly increases.
As to anti-microsomal autoantibodies, it has also been reported that IgG1 subclass of autoantibodies is major to be 49%, IgG3 is little and that IgG4 markedly increases to 38% (Parkes et al., 1984) . Three sera from patients 2, 5, and 11, out of 14 showed a remarkable increase in IgG4 subclass autoantibodies. Aalberse et al. (1983) have hypothesized that IgG4 antibodies become prominent upon chronic antigenic stimulation from their study on anti-phospholipase antibodies of beekeepers. If this is the case, patients with an increase in IgG4 subclass autoantibodies might have suffered from autoimmune thyroid diseases for a longer period than patients with normal distribution of IgG4 subclass autoantibodies.
In two groups, Graves' disease and Hashimoto's thyroiditis, percentages of IgG1 and IgG2 subclasses in IgG class of autoantibodies were statistically different from each other (p<0.005, Table 4 ). However, it is unknown at present what these differences mean, although IgG1 is more efficient in the fixation of complement than IgG2 (Spiegelberg, 1974 Dean et al., 1983 .
